U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H52O2
Molecular Weight 396.6899
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CEROTIC ACID

SMILES

CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O

InChI

InChIKey=XMHIUKTWLZUKEX-UHFFFAOYSA-N
InChI=1S/C26H52O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26(27)28/h2-25H2,1H3,(H,27,28)

HIDE SMILES / InChI
Molecular Formula C26H52O2
Molecular Weight 396.6899
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

2018
425
PubMed

PubMed

TitleDatePubMed
Screening assay of very long chain fatty acids in human plasma with multiwalled carbon nanotube-based surface-assisted laser desorption/ionization mass spectrometry.
2010-08-15
Investigation of stratum corneum lipid model membranes with free fatty acid composition by neutron diffraction.
2010-07
Plant neighbor identity influences plant biochemistry and physiology related to defense.
2010-06-17
Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000.
2010-06-01
Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
2010-05-15
Phytochemical investigation of the fruit peels of Citrus reticulata Blanco.
2010-04
[Chemical constituents of rhizomes of Zingiber officinale].
2010-03
X-linked adrenoleukodystrophy: clinical course and minimal incidence in South Brazil.
2010-03
Lovastatin in X-linked adrenoleukodystrophy.
2010-01-21
Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.
2009-12-21
Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.
2009-12
Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins: implications for adrenoleukodystrophy.
2009-11-27
Composition of diethyl ether flower extracts of Lonicera fragrantissima Lindl. & Paxton (caprifoliaceae).
2009-11
A fast method for the identification of Mycobacterium tuberculosis in sputum and cultures based on thermally assisted hydrolysis and methylation followed by gas chromatography-mass spectrometry.
2009-08-28
Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.
2009-08-01
Concentrations of very long-chain fatty acid in whole blood are associated with cardiovascular risk factors in children.
2009-03
Odd-numbered very-long-chain fatty acids from the microbial, animal and plant kingdoms.
2009-02-02
Plasmalogens participate in very-long-chain fatty acid-induced pathology.
2009-02
Epicuticular lipids induce aggregation in Chagas disease vectors.
2009-01-27
[Studies on chemical constituents of aerial roots of Ficus microcarpa].
2009-01
A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.
2009-01
Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages.
2008-11-28
[The effect of ion-exchange treatment on the fracture resistance of hot pressable ceramic crown].
2008-08
Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
2008-06-15
High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men.
2008-05
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function.
2008-05
A simple and sensitive liquid chromatographic method for the analysis of free docosanoic, tetracosanoic and hexacosanoic acids in human plasma as fluorescent derivatives.
2008-03-17
Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
2008-03
Down-regulation of fatty acid synthase increases the resistance of Saccharomyces cerevisiae cells to H2O2.
2007-11-15
Audition: a better way to treat and communicate.
2007-11
Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy.
2007-11
New flavonoids and other constituents from Lespedeza cuneata.
2007-10-19
[Studies on chemical constituents of Heterosmilax yunnanensis].
2007-08
Rapid determination of C12-C26 non-derivatized fatty acids in human serum by fast gas chromatography.
2007-07
Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans.
2007-06
Novel free ceramides as components of the soldier defense gland of the Formosan subterranean termite (Coptotermes formosanus).
2007-03
[Measurement and comparison of the spectral transmittance of cerinate porcelain and human enamel].
2006-12
Compounds with DNA cleaving activity from Kadsura ananosma.
2006-10
The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
2006-09-25
Alternative to veneers.
2006-04-06
Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.
2006-03-29
Simplified restorative correction of the dentition using contact lens-thin porcelain veneers: a report of three cases.
2006-01
11-Methoxyviburtinal, a new iridoid from Valeriana jatamansi.
2005-10
Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
2005-07
No-preparation porcelain veneers--back to the future!
2005-03
Lip1p: a novel subunit of acyl-CoA ceramide synthase.
2005-02-23
Clinical evaluation of 546 tetracycline-stained teeth treated with porcelain laminate veneers.
2005-01
A novel coaxial electrospray ionization method for characterizing hexacosanoylceramides by Fourier transform ion cyclotron resonance mass spectrometry.
2005
Direct determination of unbound lipophilic ligands in aqueous solutions.
2004
The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland.
1982-03
Patents

Patents

JPS5697208A
1
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:46:30 GMT 2025
Edited
by admin
on Mon Mar 31 19:46:30 GMT 2025
Record UNII
D42CQN6P36
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-4205
Preferred Name English
CEROTIC ACID
INCI  
INCI  
Official Name English
N-HEXACOSANOIC ACID
Common Name English
CERINIC ACID
Common Name English
CERIC ACID
Common Name English
CERATINIC ACID
Common Name English
HEXACOSANOIC ACID
Systematic Name English
Code System Code Type Description
CAS
506-46-7
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
MESH
C017364
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
FDA UNII
D42CQN6P36
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
CHEBI
31009
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
PUBCHEM
10469
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
RXCUI
1997245
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
ALTERNATIVE
RXCUI
1997246
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
NSC
4205
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
EPA CompTox
DTXSID7075050
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
WIKIPEDIA
CEROTIC ACID
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
CHEBI
31013
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
DAILYMED
D42CQN6P36
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-040-2
Created by admin on Mon Mar 31 19:46:30 GMT 2025 , Edited by admin on Mon Mar 31 19:46:30 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966